Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease

Jason Chia Hsien Cheng, Jian Kuen Wu, Patricia Chiao Tzu Lee, Hua Shan Liu, James Jer Min Jian, Yu Mong Lin, Juei Low Sung, Gwo Jen Jan

研究成果: 雜誌貢獻文章同行評審

133 引文 斯高帕斯(Scopus)

摘要

Purpose: To identify the factors associated with radiation-induced liver disease (RILD) and to describe the difference in normal tissue complication probability (NTCP) between subgroups of hepatocellular carcinoma patients undergoing three-dimensional conformal radiotherapy (3D-CRT). Methods and Materials: A total of 89 hepatocellular carcinoma patients who completed 3D-CRT for local hepatic tumors were included. The average isocenter dose was 49.9 ± 6.2 Gy. Logistic regression analysis was used for the association between statistically significant factors and RILD (defined as Grade 3 or 4 hepatic toxicity of elevated transaminases or alkaline phosphatase within 4 months of completing 3D-CRT) in multivariate analysis. Maximal likelihood analysis was conducted to obtain the best estimates of the NTCP model parameters. Results: Of the 89 patients, 17 developed RILD. In univariate analysis, hepatitis B virus (HBV)-positive status and the mean radiation dose to the liver were the two factors significantly associated with the development of RILD. Of the 65 patients who were HBV carriers, 16 had RILD compared with 1 of 24 non-carrier patients (p = 0.03). The mean radiation dose to liver was significantly greater in patients with RILD (22.9 vs. 19.0 Gy, p = 0.05). On multivariate analysis, HBV carrier status (odds ratio, 9.26; p = 0.04) and Child-Pugh B cirrhosis of the liver (odds ratio, 3.65; p = 0.04) remained statistically significant. The best estimates of the NTCP parameters were n = 0.35, m = 0.39, and TD 50(1) = 49.4 Gy. The n, m, TD 50(1) specifically estimated from the HBV carriers was 0.26, 0.40, and 50.0 Gy, respectively, compared with 0.86, 0.31, and 46.1 Gy, respectively, for non-carrier patients. Conclusion: Hepatocellular carcinoma patients who were HBV carriers or had Child-Pugh B cirrhosis presented with a statistically significantly greater susceptibility to RILD after 3D-CRT.

原文英語
頁(從 - 到)1502-1509
頁數8
期刊International Journal of Radiation Oncology Biology Physics
60
發行號5
DOIs
出版狀態已發佈 - 十二月 1 2004
對外發佈Yes

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

指紋 深入研究「Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease」主題。共同形成了獨特的指紋。

引用此